Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

Nature Genetics

Volumn 42, Issue 7, 2010, Pages 579-589

  Voight, Benjamin F ^a,b,c   Scott, Laura J ^d   Steinthorsdottir, Valgerdur ^e   Morris, Andrew P ^f   Dina, Christian ^g,h   Welch, Ryan P ^d   Zeggini, Eleftheria ^f,i   Huth, Cornelia ^j,k   Aulchenko, Yurii S ^l   Thorleifsson, Gudmar ^e   McCulloch, Laura J ^m   Ferreira, Teresa ^f   Grallert, Harald ^j,k   Amin, Najaf ^l   Wu, Guanming ⁿ   Willer, Cristen J ^d   Raychaudhuri, Soumya ^a,b,o   McCarroll, Steve A ^a,c   Langenberg, Claudia ^p   Hofmann, Oliver M ^q   Dupuis, Josée ^r,s   Qi, Lu ^o,q   Segrè, Ayellet V ^a,b,c   Van Hoek, Mandy ^l   Navarro, Pau ^t   Ardlie, Kristin ^a   Balkau, Beverley ^u   Benediktsson, Rafn ^v,w   Bennett, Amanda J ^m   Blagieva, Roza ^x   Boerwinkle, Eric ^y   Bonnycastle, Lori L ^z   Boström, Kristina Bengtsson ^aa   Bravenboer, Bert ^ab   Bumpstead, Suzannah ⁱ   Burtt, Noisël P ^a   Charpentier, Guillaume ^ac   Chines, Peter S ^z   Cornelis, Marilyn ^o   Couper, David J ^ad   Crawford, Gabe ^a   Doney, Alex S F ^ae   Elliott, Katherine S ^f   Elliott, Amanda L ^a,c   Erdos, Michael R ^z   Fox, Caroline S ^o,s   Franklin, Christopher S ^af   Ganser, Martha ^d   Gieger, Christian ^j   Grarup, Niels ^ag   Green, Todd ^a,b   Griffin, Simon ^p   Groves, Christopher J ^m   Guiducci, Candace ^a   Hadjadj, Samy ^ah   Hassanali, Neelam ^m   Herder, Christian ^ai   Isomaa, Bo ^aj,ak   Jackson, Anne U ^d   Johnson, Paul R V ^al   Jørgensen, Torben ^am,an   Kao, Wen H L ^ao,ap   Klopp, Norman ^j   Kong, Augustine ^e   Kraft, Peter ^q   Kuusisto, Johanna ^aq   Lauritzen, Torsten ^ar   Li, Man ^ao   Lieverse, Aloysius ^as   Lindgren, Cecilia M ^f   Lyssenko, Valeriya ^at   Marre, Michel ^h,au   Meitinger, Thomas ^j,av   Midthjell, Kristian ^aw   Morken, Mario A ^z   Narisu, Narisu ^z   Nilsson, Peter ^at   Owen, Katharine R ^m   Payne, Felicity ⁱ   Perry, John R B ^ax   Petersen, Ann Kristin ^j   Platou, Carl ^aw   Proença, Christine ^g   Prokopenko, Inga ^f,m   Rathmann, Wolfgang ^ai   Rayner, N William ^f,m   Robertson, Neil R ^f,m   Rocheleau, Ghislain ^ay,az   Roden, Michael ^ai   Sampson, Michael J ^ba   Saxena, Richa ^a,b,c   Shields, Beverley M ^ax   Shrader, Peter ^b,c   Sigurdsson, Gunnar ^v,w   Sparsø, Thomas ^ag   Strassburger, Klaus ^ai   Stringham, Heather M ^d   Sun, Qi ^q   Swift, Amy J ^z   Thorand, Barbara ^j   Tichet, Jean ^bb   Tuomi, Tiinamaija ^aj,bc   Van Dam, Rob M ^o   Van Haeften, Timon W ^bd   Van Herpt, Thijs ^l,as   Van Vliet Ostaptchouk, Jana V ^be   Walters, G Bragi ^e   Weedon, Michael N ^ax   Wijmenga, Cisca ^bf   Witteman, Jacqueline ^l   Bergman, Richard N ^bg   Cauchi, Stephane ^g   Collins, Francis S ^bh   Gloyn, Anna L ^m   Gyllensten, Ulf ^bi   Hansen, Torben ^ag,bj   Hide, Winston A ^q   Hitman, Graham A ^bk   Hofman, Albert ^l   Hunter, David J ^q   Hveem, Kristian ^aw,bl   Laakso, Markku ^aq   Mohlke, Karen L ^bm   Morris, Andrew D ^ae   Palmer, Colin N A ^ae   Pramstaller, Peter P ^bn   Rudan, Igor ^af,bo,bp   Sijbrands, Eric ^l   Stein, Lincoln D ⁿ   Tuomilehto, Jaakko ^bq,br,bs   Uitterlinden, Andre ^l   Walker, Mark ^bt   Wareham, Nicholas J ^p   Watanabe, Richard M ^bg   Abecasis, Gonçalo R ^d   Boehm, Bernhard O ^x   Campbell, Harry ^af   Daly, Mark J ^a,b   Hattersley, Andrew T ^ax   Hu, Frank B ^o,q   Meigs, James B ^b,c   Pankow, James S ^bu   Pedersen, Oluf ^ag,an,ar   Wichmann, H Erich ^j,k,bv   Barroso, Inês ⁱ   Florez, Jose C ^a,b,c   Frayling, Timothy M ^ax   Groop, Leif ^at,bc   Sladek, Rob ^ay,az   Thorsteinsdottir, Unnur ^e,bw   Wilson, James F ^af   Illig, Thomas ^j   Froguel, Philippe ^c,bx   Van Duijn, Cornelia M ^l   Stefansson, Kari ^e,bw   Altshuler, David ^a,b,c   Boehnke, Michael ^d   McCarthy, Mark I ^f,m,by   more..

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e DECODE GENETICS   (Iceland)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g Institut Pasteur de Lille   (France)

^h INSERM   (France)

ⁱ WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^j INSTITUTE OF EPIDEMIOLOGY   (Germany)

^k UNIVERSITY OF MUNICH   (Germany)

^l ERASMUS MEDICAL CENTER   (Netherlands)

^m UNIVERSITY OF OXFORD   (United Kingdom)

ⁿ ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^o BRIGHAM AND WOMEN S HOSPITAL   (United States)

^p ADDENBROOKE S HOSPITAL   (United Kingdom)

^q HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^r BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^s FRAMINGHAM HEART STUDY   (United States)

^t WESTERN GENERAL HOSPITAL   (United Kingdom)

^u CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^v LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^w ICELANDIC HEART ASSOCIATION   (Iceland)

^x UNIVERSITY OF ULM   (Germany)

^y UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^z NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^aa Research and Development Centre   (Sweden)

^ab CATHARINA HOSPITAL   (Netherlands)

^ac CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^ad IL   (United States)

^ae UNIVERSITY OF DUNDEE   (United Kingdom)

^af UNIVERSITY OF EDINBURGH   (United Kingdom)

^ag HAGEDORN RESEARCH INSTITUTE   (Denmark)

^ah UNIVERSITÉ DE POITIERS   (France)

^ai HEINRICH HEINE UNIVERSITY   (Germany)

^aj FOLKHÄLSAN RESEARCH CENTER   (Finland)

^ak Malmska Municipal Health Care Center and Hospital   (Finland)

^al UNIVERSITY OF OXFORD   (United Kingdom)

^am GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^an UNIVERSITY OF COPENHAGEN   (Denmark)

^ao JOHNS HOPKINS UNIVERSITY   (United States)

^ap JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aq KUOPIO UNIVERSITY HOSPITAL   (Finland)

^ar AARHUS UNIVERSITY   (Denmark)

^as MÁXIMA MEDICAL CENTER   (Netherlands)

^at LUND UNIVERSITY   (Sweden)

^au BICHAT HOSPITAL   (France)

^av TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^aw NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^ax UNIVERSITY OF EXETER   (United Kingdom)

^ay MCGILL UNIVERSITY   (Canada)

^az MCGILL UNIVERSITY   (Canada)

^ba NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^bb IRSA Institut Inter Régional Pour la Santé   (France)

^bc HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^bd UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^be UNIVERSITY OF GRONINGEN   (Netherlands)

^bf UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^bg UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^bh NATIONAL INSTITUTES OF HEALTH   (United States)

^bi UPPSALA UNIVERSITY   (Sweden)

^bj UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^bk QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^bl Levanger Hospital   (Norway)

^bm UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^bn INSTITUTE FOR RENEWABLE ENERGY   (Italy)

^bo UNIVERSITY OF SPLIT   (Croatia)

^bp SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^bq UNIVERSITY OF HELSINKI   (Finland)

^br SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

^bs HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^bt NEWCASTLE UNIVERSITY   (United Kingdom)

^bu UNIVERSITY OF MINNESOTA   (United States)

^bv LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^bw UNIVERSITY OF ICELAND   (Iceland)

^bx HAMMERSMITH HOSPITAL   (United Kingdom)

^by NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DUSP9 GENE; GENE; GENE LOCUS; GENETIC ASSOCIATION; HNF1A GENE; HUMAN; HUMAN TISSUE; KCNQ1 GENE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DUAL-SPECIFICITY PHOSPHATASES; FASTING; GENE DOSAGE; GENE EXPRESSION PROFILING; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; KCNQ1 POTASSIUM CHANNEL; META-ANALYSIS AS TOPIC; MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77954143522     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.609     Document Type: Article

References (69)

1. Stumvoll, M., Goldstein, B.J. & van Haeften, T.W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365, 1333-1346 (2005).
2. Sladek, R. et al. A genome-wide association study identifes novel risk loci for type 2 diabetes. Nature 445, 881-885 (2007).
3. Zeggini, E. et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316, 1336-1341 (2007).
4. Saxena, R. et al. Genome-wide association analysis identifes loci for type 2 diabetes and triglyceride levels. Science 316, 1331-1336 (2007).
5. Scott, L.J. et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-1345 (2007).
6. Steinthorsdottir, V. et al. A variant in CDKAL1 infuences insulin response and risk of type 2 diabetes. Nat. Genet. 39, 770-775 (2007).
7. Zeggini, E. et al. Meta-analysis of genome-wide association data and large-scale replication identifes additional susceptibility loci for type 2 diabetes. Nat. Genet. 40, 638-645 (2008).
8. Yasuda, K. et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat. Genet. 40, 1092-1097 (2008).
9. Unoki, H. et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat. Genet. 40, 1098-1102 (2008).
10. Rung, J. et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat. Genet. 41, 1110-1115 (2009).
11. Kong, A. et al. Parental origin of sequence variants associated with complex diseases. Nature 462, 868-874 (2009).
12. Dupuis, J. et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 42, 105-116 (2010).
13. Saxena, R. et al. Genetic variation in gastric inhibitory polypeptide receptor (GIPR) impacts the glucose and insulin responses to an oral glucose challenge. Nat. Genet. 42, 142-148 (2010).
14. Prokopenko, I. et al. Variants in MTNR1B infuence fasting glucose levels. Nat. Genet. 41, 77-81 (2009).
15. Bouatia-Naji, N. et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat. Genet. 41, 89-94 (2009).
16. Lyssenko, V. et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat. Genet. 41, 82-88 (2009).
17. Fitzpatrick, G.V., Soloway, P.D. & Higgins, M.J. Regional loss of imprinting and growth defciency in mice with a targeted deletion of KvDMR1. Nat. Genet. 32, 426-431 (2002).
18. Kassem, S.A. et al. p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes 50, 2763-2769 (2001).
19. Newton-Cheh, C. et al. Common variants at ten loci infuence QT interval duration in the QTGEN Study. Nat. Genet. 41, 399-406 (2009).
20. Pfeufer, A. et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat. Genet. 41, 407-414 (2009).
21. Winckler, W. et al. Association of common variation in the HNF1α gene region with risk of type 2 diabetes. Diabetes 54, 2336-2342 (2005).
22. Weedon, M.N. et al. A large-scale association analysis of common variation of the HNF1α gene with type 2 diabetes in the U.K. Caucasian population. Diabetes 54, 2487-2491 (2005).
23. Bonnycastle, L.L. et al. Common variants in maturity-onset diabetes of the young genes contribute to risk of type 2 diabetes in Finns. Diabetes 55, 2534-2540 (2006).
24. Hegele, R.A., Cao, H., Harris, S.B., Hanley, A.J. & Zinman, B. The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. J. Clin. Endocrinol. Metab. 84, 1077-1082 (1999).
25. Kobberling, J. & Tillil, H. Empirical risk fgures for frst degree relatives of non-insulin-dependent diabetics. in The Genetics of Diabetes Mellitus (eds. Kobberling, J. & Tattersall, R.) 201-209 (Academic Press, New York, 1982).
26. Manolio, T.A. et al. Finding the missing heritability of complex diseases. Nature 461, 747-753 (2009).
27. Browning, B.L. & Browning, S.R. Haplotypic analysis of Wellcome Trust Case Control Consortium data. Hum. Genet. 123, 273-280 (2008).
28. Weedon, M.N. et al. A common variant of HMGA2 is associated with adult and childhood height in the general population. Nat. Genet. 39, 1245-1250 (2007).
29. Stacey, S.N. et al. New common variants affecting susceptibility to basal cell carcinoma. Nat. Genet. 41, 909-914 (2009).
30. Kathiresan, S. et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56-65 (2009).
31. Reiner, A.P. et al. Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am. J. Hum. Genet. 82, 1193-1201 (2008).
32. Ridker, P.M. et al. Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am. J. Hum. Genet. 82, 1185-1192 (2008).
33. Elliott, P. et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. J. Am. Med. Assoc. 302, 37-48 (2009).
34. Helgadottir, A. et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat. Genet. 40, 217-224 (2008).
35. Samani, N.J. et al. Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 357, 443-453 (2007).
36. McPherson, R. et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316, 1488-1491 (2007).
37. Thomas, G. et al. Multiple loci identifed in a genome-wide association study of prostate cancer. Nat. Genet. 40, 310-315 (2008).
38. Barrett, J.C. et al. Genome-wide association defnes more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40, 955-962 (2008).
39. Johansson, A. et al. Common variants in the JAZF1 gene associated with height identifed by linkage and genome-wide association analysis. Hum. Mol. Genet. 18, 373-380 (2009).
40. Quaranta, M. et al. Differential contribution of CDKAL1 variants to psoriasis, Crohn's disease and type II diabetes. Genes Immun. 10, 654-658 (2009).
41. Hindorff, L.A. et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. USA 106, 9362-9367 (2009).
42. Nicolson, T.J. et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 58, 2070-2083 (2009).
43. Willer, C.J. et al. Six new loci associated with body mass index highlight a neuronal infuence on body weight regulation. Nat. Genet. 41, 25-34 (2009).
44. Florez, J.C. Newly identifed loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 51, 1100-1110 (2008).
45. Anand, A. & Chada, K. In vivo modulation of Hmgic reduces obesity. Nat. Genet. 24, 377-380 (2000).
46. Boesgaard, T.W. et al. Variant near ADAMTS9 known to associate with type 2 diabetes is related to insulin resistance in offspring of type 2 diabetes patients-EUGENE2 study. PLoS One 4, e7236 (2009).
47. Emilsson, V. et al. Genetics of gene expression and its effect on disease. Nature 452, 423-428 (2008).
48. Wang, K. et al. Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am. J. Hum. Genet. 84, 399-405 (2009).
49. Raychaudhuri, S. et al. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet. 5, e1000534 (2009).
50. Mi, H. et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res. 33, D284-D288 (2005).
51. Matthews, L. et al. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res. 37, D619-D622 (2009).
52. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profles. Proc. Natl. Acad. Sci. USA 102, 15545-15550 (2005).
53. Brants, J.R. et al. Differential regulation of the insulin-like growth factor II mRNA-binding protein genes by architectural transcription factor HMGA2. FEBS Lett. 569, 277-283 (2004).
54. Cleynen, I. et al. HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor-kappaB. Mol. Cancer Res. 5, 363-372 (2007).
55. Groenewoud, M.J. et al. Variants of CDKAL1 and IGF2BP2 affect frst-phase insulin secretion during hyperglycaemic clamps. Diabetologia 51, 1659-1663 (2008).
56. Brantjes, H., Roose, J., van De Wetering, M. & Clevers, H. All Tcf HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Res. 29, 1410-1419 (2001).
57. Logeat, F. et al. The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc. Natl. Acad. Sci. USA 95, 8108-8112 (1998).
58. Gordon, W.R. et al. Effects of S1 cleavage on the structure, surface export, and signaling activity of human Notch1 and Notch2. PLoS One 4, e6613 (2009).
59. Somerville, R.P. et al. Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J. Biol. Chem. 278, 9503-9513 (2003).
60. Parker-Katiraee, L. et al. Identifcation of the imprinted KLF14 transcription factor undergoing human-specifc accelerated evolution. PLoS Genet. 3, e65 (2007).
61. Emanuelli, B., Eberlé, D., Suzuki, R. & Kahn, C.R. Overexpression of the dual-specifcity phosphatase MKP-4/DUSP-9 protects against stress-induced insulin resistance. Proc. Natl. Acad. Sci. USA 105, 3545-3550 (2008).
62. Xu, H. et al. Dual specifcity mitogen-activated protein (MAP) kinase phosphatase-4 plays a potential role in insulin resistance. J. Biol. Chem. 278, 30187-30192 (2003).
63. Dimas, A.S. et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 325, 1246-1250 (2009).
64. Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997-1004 (1999).
65. Higgins, J.P., Thompson, S.G., Deeks, J.J. & Altman, D.G. Measuring inconsistency in meta-analyses. Br. Med. J. 327, 557-560 (2003).
66. Lin, S., Chakravarti, A. & Cutler, D.J. Exhaustive allelic transmission disequilibrium tests as a new approach to genome-wide association studies. Nat. Genet. 36, 1181-1188 (2004).
67. Matthews, D.R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-1409 (1985).
68. Stolerman, E.S. et al. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study. Diabetologia 52, 614-620 (2009).
69. Stefansson, H. et al. A common inversion under selection in Europeans. Nat. Genet. 37, 129-137 (2005).